Vanguard Group Inc Precigen, Inc. Transaction History

Vanguard Group Inc

  • $5.37 Trillion
  • Q1 2025

A detailed history of Vanguard Group Inc transactions in Precigen, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 8,795,959 shares of PGEN stock, worth $16.1 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
8,795,959
Previous 8,330,491 5.59%
Holding current value
$16.1 Million
Previous $9.33 Million 40.46%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 09, 2025
BUY
$1.07 - $2.03 $498,050 - $944,900
465,468 Added 5.59%
8,795,959 $13.1 Million
Q4 2024

Feb 11, 2025
BUY
$0.67 - $1.12 $1,574 - $2,632
2,350 Added 0.03%
8,330,491 $9.33 Million
Q3 2024

Nov 13, 2024
BUY
$0.91 - $1.88 $1.43 Million - $2.95 Million
1,568,781 Added 23.21%
8,328,141 $7.91 Million
Q2 2024

Aug 13, 2024
SELL
$1.27 - $1.75 $11,269 - $15,529
-8,874 Reduced 0.13%
6,759,360 $10.7 Million
Q1 2024

May 10, 2024
BUY
$1.21 - $1.75 $24,048 - $34,781
19,875 Added 0.29%
6,768,234 $9.81 Million
Q4 2023

Feb 14, 2024
SELL
$0.89 - $1.41 $180,238 - $285,546
-202,515 Reduced 2.91%
6,748,359 $9.04 Million
Q3 2023

Nov 14, 2023
BUY
$1.08 - $1.85 $140,432 - $240,555
130,030 Added 1.91%
6,950,874 $9.87 Million
Q2 2023

Aug 14, 2023
BUY
$0.96 - $1.4 $121,789 - $177,609
126,864 Added 1.9%
6,820,844 $7.84 Million
Q1 2023

May 15, 2023
BUY
$0.88 - $2.19 $1.59 Million - $3.97 Million
1,811,840 Added 37.11%
6,693,980 $7.1 Million
Q4 2022

Feb 10, 2023
SELL
$1.27 - $2.26 $260,765 - $464,039
-205,327 Reduced 4.04%
4,882,140 $7.42 Million
Q3 2022

Nov 14, 2022
SELL
$1.41 - $2.79 $18,379 - $36,367
-13,035 Reduced 0.26%
5,087,467 $10.8 Million
Q2 2022

Aug 12, 2022
SELL
$1.15 - $2.53 $3.1 Million - $6.82 Million
-2,694,905 Reduced 34.57%
5,100,502 $6.83 Million
Q1 2022

May 13, 2022
SELL
$1.91 - $3.98 $4.34 Million - $9.04 Million
-2,270,908 Reduced 22.56%
7,795,407 $16.4 Million
Q4 2021

Feb 14, 2022
BUY
$3.53 - $5.5 $3.09 Million - $4.81 Million
875,306 Added 9.52%
10,066,315 $37.3 Million
Q3 2021

Nov 12, 2021
BUY
$4.99 - $6.55 $153,232 - $201,137
30,708 Added 0.34%
9,191,009 $45.9 Million
Q2 2021

Aug 13, 2021
BUY
$6.24 - $8.22 $57.2 Million - $75.3 Million
9,160,301 New
9,160,301 $59.7 Million

Others Institutions Holding PGEN

# of Institutions
153
Shares Held
165M
Call Options Held
1.11M
Put Options Held
36.8K
View Full List

About PRECIGEN, INC.

PGEN Quotes by TradingView
  • Ticker PGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 208,150,000
  • Market Cap $381M
  • Description
  • Precigen, Inc. discovers and develops the next generation of gene and cellular therapies in the United States. It also provides disease-modifying therapeutics; genetically engineered swine for regenerative medicine applications; and reproductive and embryo transfer technologies. In addition, the company offers UltraVector platform that incorpora...
More about PGEN
Track This Portfolio

Track Vanguard Group Inc Portfolio

Follow Vanguard Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email